Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Mar;11(3):415–419. doi: 10.1128/aac.11.3.415

Chemically Defined Antimicrobial Susceptibility Test Medium for Pseudomonas aeruginosa

J H Jorgensen *, J C Lee 1, P M Jones 1
PMCID: PMC352000  PMID: 404961

Abstract

A chemically defined growth medium containing physiological concentrations of magnesium and calcium ions was utilized in a microdilution procedure for antimicrobial drug susceptibility testing of Pseudomonas aeruginosa. Determinations of growth end points were simplified by use of sodium citrate as a sole carbon source and bromothymol blue as a pH indicator. Growth of the test organisms was detectable by a change in the indicator color from green to blue after alkalinization of the medium due to citrate utilization. Minimal inhibitory concentrations of amikacin, carbenicillin, gentamicin, and tobramycin were determined on 100 recent clinical isolates of Pseudomonas. Parallel determinations using the microdilution procedure and a conventional tube-broth dilution technique incorporating Mueller-Hinton broth with identical magnesium and calcium content generally agreed within one twofold dilution. Modal minimal inhibitory concentrations for susceptible strains using the microdilution method were: amikacin, 6 μg/ml; carbenicillin, 50 μg/ml; gentamicin, 1.5 μg/ml; tobramycin, 1.5 μg/ml. This modified microdilution technique allowed rapid, definitive minimal inhibitory concentration determinations, using growth end points defined by a color indicator change.

Full text

PDF
415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATUK N. O., MOSCA A., KUNIN C. THE USE OF POTENTIALLY NEPHROTOXIC ANTIBIOTICS IN THE TREATMENT OF GRAM-NEGATIVE INFECTIONS IN UREMIC PATIENTS. Ann Intern Med. 1964 Jan;60:28–38. doi: 10.7326/0003-4819-60-1-28. [DOI] [PubMed] [Google Scholar]
  2. D'amato R. F., Thornsberry C., Baker C. N., Kirven L. A. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob Agents Chemother. 1975 May;7(5):596–600. doi: 10.1128/aac.7.5.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis S. D., Iannetta A. Influence of serum and calcium on the bactericidal activity of gentamicin and carbenicillin on Pseudomonas aeruginosa. Appl Microbiol. 1972 Apr;23(4):775–779. doi: 10.1128/am.23.4.775-779.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Duncan I. B. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother. 1974 Jan;5(1):9–15. doi: 10.1128/aac.5.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garrod L. P., Waterworth P. M. Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol. 1969 Sep;22(5):534–538. doi: 10.1136/jcp.22.5.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harwick H. J., Weiss P., Fekety F. R., Jr Application of microtitration techniques to bacteriostatic and bactericidal antibiotic susceptibility testing. J Lab Clin Med. 1968 Sep;72(3):511–516. [PubMed] [Google Scholar]
  7. Kunin C. M. A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. Ann Intern Med. 1967 Jul;67(1):151–158. doi: 10.7326/0003-4819-67-1-151. [DOI] [PubMed] [Google Scholar]
  8. Lockwood W. R., Lawson L. A. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials. Antimicrob Agents Chemother. 1973 Sep;4(3):281–284. doi: 10.1128/aac.4.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis. 1974 Nov;130(5):454–463. doi: 10.1093/infdis/130.5.454. [DOI] [PubMed] [Google Scholar]
  10. Reynolds A. V., Hamilton-Miller J. M., Brumfitt W. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin. Br Med J. 1974 Sep 28;3(5934):778–780. doi: 10.1136/bmj.3.5934.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tippett L. O., Zeleznick L. D., Robb C. A. Modification of the microtiter technique for antimicrobial drug susceptibility testing by incorporation of indicators. Appl Microbiol. 1970 Sep;20(3):342–345. doi: 10.1128/am.20.3.342-345.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Waterworth P. M. The in-vitro activity of tobramycin compared with that of other aminoglycosides. J Clin Pathol. 1972 Nov;25(11):979–983. doi: 10.1136/jcp.25.11.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zimelis V. M., Jackson G. G. Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis. 1973 Jun;127(6):663–669. doi: 10.1093/infdis/127.6.663. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES